Author Archives: Guest Blogger

UK: Further Steps Toward Value-Based Assessment

By Leela Barham. The National Institute for Health and Care Excellence (NICE) has finally published the formal consultation on value-based assessment (VBA). VBA is the new VBP, incorporating a wider assessment of value and no longer clearly linking to price in quite the way that some speculated all the way back in 2010 when VBP […]
Posted in Europe, Guest Blog, Op-Ed, pricing, Regulatory | Tagged , , , , , , | Leave a comment

Making the Most of Disruptive Digital Technologies

Peter Houston looks at the pharma marketing takeaways from last week’s Digital Innovation Summit.
Posted in E-Media, Europe, Events, Global, Marketing, multimedia, Op-Ed, social media, Technology | Tagged , , , | Leave a comment

Adaptive Licensing: The Start of a Slow Revolution in Europe

By Peter O’ Donnell. So at last it’s happened. Adaptive licensing has leapt from the pages of learned journals into the real world of European regulation. Is this the beginning of the end of binary decision-making on the merits of a new medicine? Has a half-century of the “yes/no” authorization process peaked, to be replaced […]
Posted in Europe, Global, Guest Blog, Op-Ed, R&D, Regulatory, Safety | Tagged , , , , , | Leave a comment

The Broken Clinical Research System

Dr. Greg Koski of the Alliance for Clinical Research Excellence and Safety (ACRES) talks to Moe Alsumidaie of Applied Clinical Trials about the urgent need for change in the clinical research industry.
Posted in Guest Blog, R&D | Tagged , , | 1 Comment

UK Drug Pricing: An ICER of Zero?

by Leela Barham The incremental cost effectiveness ratio (ICER) – or the threshold for determining whether the costs of a new medicine are worth it – has been controversial since it’s inception. There are those who deny that anyone can put a price-tag on life; those that accept the concept but are happy to let […]
Posted in Europe, Guest Blog, healthcare, Legal, Market Access, pricing, Regulatory, Strategy | Tagged , , , , , | Leave a comment
  • Categories

  • Meta